GRCE

$GRCEGrace Therapeutics, Inc.

Opaleye Management Inc. — buy in Grace Therapeutics, Inc.

10% owner

11,233 shares @ $1.93 · ~$22K · code P

$GRCEGrace Therapeutics, Inc.

Opaleye Management Inc. — buy in Grace Therapeutics, Inc.

10% owner

2,077 shares @ $2.02 · ~$4K · code P

$GRCEGrace Therapeutics, Inc.

Opaleye Management Inc. — buy in Grace Therapeutics, Inc.

10% owner

9,771 shares @ $2.1 · ~$21K · code P

$GRCEGrace Therapeutics, Inc.

NEUGEBOREN EDWARD — grant in Grace Therapeutics, Inc.

12,200 shares · code A

$GRCEGrace Therapeutics, Inc.

Kohli Prashant — buy in Grace Therapeutics, Inc.

Chief Executive Officer

100,000 shares @ $2.14 · ~$214K · code P

$GRCEGrace Therapeutics, Inc.

Kumar Amresh — grant in Grace Therapeutics, Inc.

VP Program Management

35,760 shares · code A

$GRCEGrace Therapeutics, Inc.

Macdonald R. Loch — grant in Grace Therapeutics, Inc.

Chief Medical Officer

54,690 shares · code A

$GRCEGrace Therapeutics, Inc.

Kohli Prashant — grant in Grace Therapeutics, Inc.

Chief Executive Officer

267,160 shares · code A

$GRCEGrace Therapeutics, Inc.

DelAversano Robert J — grant in Grace Therapeutics, Inc.

Principal Financial Officer

33,660 shares · code A

$GRCEGrace Therapeutics, Inc.

Opaleye Management Inc. — buy in Grace Therapeutics, Inc.

10% owner

11,608 shares @ $2.09 · ~$24K · code P